Background: Recently, radiomics has emerged as a possible image-derived biomarker, predominantly stemming from retrospective analyses. We aimed to prospectively assess the predictive role of [F]FDG-PET radiomics in breast cancer (BC).
Methods: Patients affected by stage I-III BC eligible for neoadjuvant chemotherapy (NAC) staged with [F]FDG-PET/CT were prospectively enrolled.